World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
60
Citations
11991
World Ranking
3572
National Ranking
228

Overview

Ariel Graff-Guerrero is affiliated with the Centre for Addiction and Mental Health in Canada, contributing extensively to research in medicine and neuroscience. Their work predominantly focuses on psychiatry and mental health, cognitive neuroscience, radiology, nuclear medicine and imaging, cellular and molecular neuroscience, and clinical psychology.

The scientist's research spans multiple specialized topics, including:

  • Functional Brain Connectivity Studies
  • Schizophrenia Research and Treatment
  • Advanced Neuroimaging Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Neuroscience and Neuropharmacology Research
  • Dementia and Cognitive Impairment Research
  • Diet and Metabolism Studies

Ariel Graff-Guerrero has published in a variety of well-regarded peer-reviewed journals. Frequent publication venues include:

  • Biological Psychiatry
  • Alzheimer's & Dementia
  • Schizophrenia Bulletin
  • The International Journal of Neuropsychopharmacology
  • PLoS ONE

Several recent papers demonstrate the scope and focus of their research efforts:

  • Individual determinants of COVID-19 vaccine hesitancy, 2021, PLoS ONE
  • Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies, 2021, Molecular Psychiatry
  • Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level, 2021, JAMA Psychiatry
  • Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment, 2022, Molecular Psychiatry
  • Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health, 2021, Schizophrenia

Their collaborative network features frequent co-authors involved in overlapping research areas, including:

  • Philip Gerretsen
  • Gary Remington
  • Bruce G. Pollock
  • Fernando Caravaggio
  • Shinichiro Nakajima

Ariel Graff-Guerrero's extensive publication record includes 157 contributions to the field of medicine and 107 in neuroscience, highlighting a broad engagement across neuropsychiatric research domains.

Best Publications

  • Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

    Oliver D. Howes;Rob McCutcheon;Ofer Agid;Andrea De Bartolomeis

  • Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies

    Sho Moriguchi;Sho Moriguchi;Akihiro Takamiya;Yoshihiro Noda;Nobuyuki Horita

  • Kynurenine pathway in depression: A systematic review and meta-analysis

    Kamiyu Ogyu;Kaoruhiko Kubo;Yoshihiro Noda;Yusuke Iwata

  • Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis

    Camilo de la Fuente-Sandoval;Pablo León-Ortiz;Rafael Favila;Sylvana Stephano

  • Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making

    Gagan Fervaha;Gagan Fervaha;Ariel Graff-Guerrero;Ariel Graff-Guerrero;Konstantine K. Zakzanis;George Foussias;George Foussias

  • Cerebral blood flow associated with creative performance: a comparative study

    Rosa Aurora Chávez-Eakle;Ariel Graff-Guerrero;Ariel Graff-Guerrero;Juan-Carlos García-Reyna;Víctor Vaugier

  • Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis: A Longitudinal Proton Magnetic Resonance Spectroscopy Study

    Camilo de la Fuente-Sandoval;Pablo León-Ortiz;Mariana Azcárraga;Sylvana Stephano

  • Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.

    Eric Plitman;Eric Plitman;Yusuke Iwata;Fernando Caravaggio;Shinichiro Nakajima

  • Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation

    Takefumi Suzuki;Gary Remington;Gary Remington;Benoit H. Mulsant;Benoit H. Mulsant;Hiroyuki Uchida;Hiroyuki Uchida

  • Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia.

    Nicole E. MacKenzie;Chantel Kowalchuk;Chantel Kowalchuk;Sri Mahavir Agarwal;Sri Mahavir Agarwal;Kenya A. Costa-Dookhan;Kenya A. Costa-Dookhan

  • Individual determinants of COVID-19 vaccine hesitancy.

    Philip Gerretsen;Philip Gerretsen;Julia Kim;Fernando Caravaggio;Lena Quilty

  • The potential role of dopamine D3 receptor neurotransmission in cognition

    Shinichiro Nakajima;Philip Gerretsen;Hiroyoshi Takeuchi;Hiroyoshi Takeuchi;Hiroyoshi Takeuchi;Fernando Caravaggio;Fernando Caravaggio

  • Glutamate-mediated excitotoxicity in schizophrenia: A review

    Eric Plitman;Eric Plitman;Shinichiro Nakajima;Camilo de la Fuente-Sandoval;Philip Gerretsen

  • Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain

    Ariel Graff-Guerrero;Jorge González-Olvera;Ana Fresán;Diana Gómez-Martín

  • Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis.

    Hiroyuki Uchida;Hiroyoshi Takeuchi;Ariel Graff-Guerrero;Takefumi Suzuki

  • Motivational deficits and cognitive test performance in schizophrenia.

    Gagan Fervaha;Gagan Fervaha;Konstantine K. Zakzanis;George Foussias;George Foussias;Ariel Graff-Guerrero;Ariel Graff-Guerrero

  • Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans : Effects of dopaminergic modulation

    Mahesh Menon;Jimmy Jensen;Jimmy Jensen;Irina Vitcu;Ariel Graff-Guerrero

  • Treatment resistant schizophrenia and response to antipsychotics: A review

    Takefumi Suzuki;Gary Remington;Gary Remington;Benoit H. Mulsant;Benoit H. Mulsant;Tarek K. Rajji

  • Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.

    Tomomi Nakahara;Sakiko Tsugawa;Yoshihiro Noda;Fumihiko Ueno

  • Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.

    Simon Jc Davies;Amer M Burhan;Donna Kim;Donna Kim;Philip Gerretsen

  • The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study.

    Ariel Graff-Guerrero;Romina Mizrahi;Romina Mizrahi;Ofer Agid;Ofer Agid;Heidi Marcon

  • Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study

    Hiroyoshi Takeuchi;Takefumi Suzuki;Gary Remington;Robert R. Bies;Robert R. Bies

Frequent Co-Authors

Tarek K. Rajji
Tarek K. Rajji Centre for Addiction and Mental Health
Masaru Mimura
Masaru Mimura Keio University
Lena C. Quilty
Lena C. Quilty Centre for Addiction and Mental Health
Corinne E. Fischer
Corinne E. Fischer St. Michael's Hospital
Zahinoor Ismail
Zahinoor Ismail University of Calgary
Konstantine K. Zakzanis
Konstantine K. Zakzanis University of Toronto
Sandra E. Black
Sandra E. Black University of Toronto
Morris Freedman
Morris Freedman University of Toronto
Alastair J. Flint
Alastair J. Flint University of Toronto
Christopher R. Bowie
Christopher R. Bowie Queen's University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring psychology in the USA opens doors to a variety of online degrees and career pathways, notably in fields like counseling and mental health support. An increasingly popular option is becoming a substance abuse counselor—a profession seeing strong demand in many communities.

Each state has different steps and standards for entering this field. For example, those interested in working in California can review the Oakland substance abuse counselor certification requirements to understand local education and licensing guidelines. Similarly, individuals looking at Oklahoma can familiarize themselves with substance abuse counselor requirements in Oklahoma City. In Nebraska, Omaha substance abuse counselor certification requirements offer a roadmap specific to that region, while those in Florida should check the Orlando substance abuse counselor certification requirements.

Choosing the right online degree is a key step for those aspiring to help others through counseling. Researching local requirements ensures you’re on the right track to licensure and meaningful career advancement.

Best Scientists Citing Ariel Graff-Guerrero

Trending Scientists

Recently Published Articles